1 false false false false false false false false false true false false false false false false No description of principal activity 2022-02-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 04352134 2022-02-01 2023-01-31 04352134 2023-01-31 04352134 2021-02-01 2022-01-31 04352134 2022-01-31 04352134 bus:Director1 2022-02-01 2023-01-31 04352134 core:WithinOneYear 2023-01-31 04352134 core:WithinOneYear 2022-01-31 04352134 core:RestatedAmount 2022-01-31 04352134 bus:Micro-entities 2022-02-01 2023-01-31 04352134 bus:AuditExempt-NoAccountantsReport 2022-02-01 2023-01-31 04352134 bus:FullAccounts 2022-02-01 2023-01-31 04352134 bus:SmallCompaniesRegimeForAccounts 2022-02-01 2023-01-31 04352134 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31
COMPANY REGISTRATION NUMBER: 04352134
Jules Pharma Limited
Filleted Unaudited Financial Statements
31 January 2023
Jules Pharma Limited
Statement of Financial Position
31 January 2023
2023
2022
£
£
£
Fixed assets
44
59
----
----
Current assets
37,859
19,962
Creditors: amounts falling due within one year
30,218
24,297
--------
--------
Net current assets/(liabilities)
7,641
( 4,335)
-------
-------
Total assets less current liabilities
7,685
( 4,276)
Accruals and deferred income
600
600
-------
-------
7,085
(4,876)
-------
-------
Capital and reserves
7,085
( 4,876)
-------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
2. Director's advances, credits and guarantees
The company is £30,217 indebted to the director at the end of the year.
For the year ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 6 October 2023 , and are signed on behalf of the board by:
Mr A. N Aghadiuno
Director
Company registration number: 04352134
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 10 Lyndhurst Road, Croydon, Surrey, CR5 3HT.